226 related articles for article (PubMed ID: 24920818)
21. Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells.
Guzmán CA; Saverino D; Medina E; Fenoglio D; Gerstel B; Merlo A; Li Pira G; Buffa F; Chakraborty T; Manca F
Eur J Immunol; 1998 Jun; 28(6):1807-14. PubMed ID: 9645361
[TBL] [Abstract][Full Text] [Related]
22. NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus.
de Lorimier R; Moody MA; Haynes BF; Spicer LD
Biochemistry; 1994 Mar; 33(8):2055-62. PubMed ID: 7509632
[TBL] [Abstract][Full Text] [Related]
23. Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition.
Liang Y; Guttman M; Davenport TM; Hu SL; Lee KK
Biochemistry; 2016 Apr; 55(15):2197-213. PubMed ID: 27003615
[TBL] [Abstract][Full Text] [Related]
24. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120.
McKeating JA; Shotton C; Cordell J; Graham S; Balfe P; Sullivan N; Charles M; Page M; Bolmstedt A; Olofsson S
J Virol; 1993 Aug; 67(8):4932-44. PubMed ID: 7687306
[TBL] [Abstract][Full Text] [Related]
25. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
[TBL] [Abstract][Full Text] [Related]
26. Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120.
Mirano-Bascos D; Steede NK; Robinson JE; Landry SJ
J Virol; 2010 Apr; 84(7):3303-11. PubMed ID: 20089653
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulins.
He Y; D'Agostino P; Pinter A
Vaccine; 2003 Oct; 21(27-30):4421-9. PubMed ID: 14505925
[TBL] [Abstract][Full Text] [Related]
28. Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain.
Wu Z; Kayman SC; Honnen W; Revesz K; Chen H; Vijh-Warrier S; Tilley SA; McKeating J; Shotton C; Pinter A
J Virol; 1995 Apr; 69(4):2271-8. PubMed ID: 7533854
[TBL] [Abstract][Full Text] [Related]
29. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
31. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
32. Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopes.
Li H; Chien PC; Tuen M; Visciano ML; Cohen S; Blais S; Xu CF; Zhang HT; Hioe CE
J Immunol; 2008 Mar; 180(6):4011-21. PubMed ID: 18322210
[TBL] [Abstract][Full Text] [Related]
33. Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18.
Gift SK; Zentner IJ; Schön A; McFadden K; Umashankara M; Rajagopal S; Contarino M; Duffy C; Courter JR; Zhang MY; Gershoni JM; Cocklin S; Dimitrov DS; Smith AB; Freire E; Chaiken IM
Biochemistry; 2011 Apr; 50(14):2756-68. PubMed ID: 21351734
[TBL] [Abstract][Full Text] [Related]
34. Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding.
Stamatatos L; Cheng-Mayer C
J Virol; 1995 Oct; 69(10):6191-8. PubMed ID: 7545244
[TBL] [Abstract][Full Text] [Related]
35. A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein.
Kelker HC; Itri VR; Valentine FT
PLoS One; 2010 Jan; 5(1):e8555. PubMed ID: 20052405
[TBL] [Abstract][Full Text] [Related]
36. Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodies.
Chen W; Feng Y; Wang Y; Zhu Z; Dimitrov DS
Biochem Biophys Res Commun; 2012 Sep; 425(4):931-7. PubMed ID: 22906742
[TBL] [Abstract][Full Text] [Related]
37. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
[TBL] [Abstract][Full Text] [Related]
38. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
Cohen S; Tuen M; Hioe CE
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
[TBL] [Abstract][Full Text] [Related]
39. Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites.
Pinter A; Honnen WJ; Tilley SA
J Virol; 1993 Sep; 67(9):5692-7. PubMed ID: 7688827
[TBL] [Abstract][Full Text] [Related]
40. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
